Chlorhexidine versus povidone-iodine for surgical site infection prevention: an updated meta-analysis and trial sequential analysis of randomized controlled trials
Chlorhexidin versus Povidon-Iod zur Prävention von Infektionen der Operationsstelle: aktualisierte Metaanalyse und Trial-Sequenzanalyse randomisierter kontrollierter Studien
Frontiers in Medicine · 20.11.2025 · 12
DOI: 10.3389/fmed.2025.1641815 ↗Auf einen Blick
32 RCTs mit 29.748 Teilnehmenden zeigen: Chlorhexidin war bei der Prävention von Infektionen der Operationsstelle Povidon-Iod überlegen. Der Vorteil zeigte sich vor allem bei clean-contaminated Eingriffen.
Fragestellung
Ist Chlorhexidin zur präoperativen Hautantiseptik wirksamer als Povidon-Iod zur Prävention von Infektionen der Operationsstelle?
Methode
Systematische Übersicht und Metaanalyse nach PRISMA; Suche in PubMed, Web of Science, Embase und Cochrane Central bis 1. Mai 2025; Random-Effects-Modell und Trial-Sequenzanalyse.
Ergebnisse
32 hochwertige RCTs mit 29.748 Teilnehmenden. Gesamt-SSI: RR 0,83 (95 %-KI 0,72–0,95; p = 0,009). Clean-contaminated: RR 0,75 (95 %-KI 0,62–0,92). Clean: kein Unterschied.
Schlussfolgerung der Autor:innen
Chlorhexidin-basierte Antiseptika sind zur Prävention von Gesamt-SSIs wirksamer als Povidon-Iod-basierte, besonders bei clean-contaminated Eingriffen. Der Vorteil betrifft vor allem oberflächliche Inzision-SSIs.
Kernaussagen
- Gesamt-SSI seltener unter Chlorhexidin: RR 0,83 (95 %-KI 0,72–0,95)
- Vorteil vor allem bei clean-contaminated Eingriffen
- Kein signifikanter Vorteil bei tiefen oder organraumbezogenen SSIs
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Medicine, online erschienen am 20.11.2025. Verfasst von Shengyi Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infection Control, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Nosokomiale Infektionen
Abstract (Originalsprache)
Background
Chlorhexidine (CHX) and povidone-iodine (PVI) are the most commonly used antiseptic agents for preoperative skin preparation to prevent surgical site infections (SSIs). This meta-analysis aimed to determine the superior agent between them for SSI prevention.
Methods
We conducted a systematic review and meta-analysis in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A comprehensive search of electronic databases (PubMed, Web of Science, Embase, and Cochrane Central Register of Controlled Trials) was performed from inception to 1 May 2025, to identify relevant randomized controlled trials (RCTs). Heterogeneity was assessed using the chi-squared (Q) test and the I 2 statistic. A random-effects model was applied when significant heterogeneity was present. The robustness of the findings was evaluated using trial sequential analysis (TSA) with a random-effects model. All statistical analyses were performed using Review Manager.
Results
A total of 32 high-quality RCTs, involving 29,748 participants, were included. The pooled analysis using a random-effects model demonstrated that CHX was significantly more effective than PVI in preventing SSIs (RR = 0.83, 95% CI 0.72–0.95, p = 0.009). Subgroup analysis by wound classification revealed that CHX was superior to PVI in clean-contaminated surgeries (11 RCTs; RR = 0.75, 95% CI 0.62–0.92, p = 0.004), but no significant difference was observed in clean surgeries (20 RCTs; RR = 0.90, 95% CI 0.67–1.20, p = 0.46). Further stratification by SSI type indicated that CHX significantly reduced the risk of superficial incisional SSIs (18 RCTs; RR = 0.82, 95% CI 0.69–0.98, p = 0.03), but not deep incisional SSIs (16 RCTs; RR = 0.95, 95% CI 0.76–1.18, p = 0.63) or organ-space SSIs (11 RCTs; RR = 1.13, 95% CI 0.89–1.42, p = 0.32). Additionally, CHX was associated with a significantly lower risk of bacterial decolonization (RR = 0.38, 95% CI 0.26–0.57, p < 0.001) and febrile episodes (RR = 0.57, 95% CI 0.35–0.92, p = 0.02) compared to PVI. The TSA confirmed the robustness of these findings, indicating that the cumulative evidence was sufficient and conclusive.
Conclusion
CHX-based antiseptics are more effective than PVI-based ones in preventing overall SSIs, particularly in clean-contaminated procedures. The superiority of CHX is primarily evident in reducing superficial incisional SSIs, with no significant advantage observed for deep incisional or organ-space SSIs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infection Control, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Zitieren
APA
Yang, S., Li, Z., Wu, F., Sun, L., He, Y., & Wang, C. (2025). Chlorhexidine versus povidone-iodine for surgical site infection prevention: an updated meta-analysis and trial sequential analysis of randomized controlled trials. Frontiers in Medicine, 12. https://doi.org/10.3389/fmed.2025.1641815
Vancouver
Yang S, Li Z, Wu F, Sun L, He Y, Wang C. Chlorhexidine versus povidone-iodine for surgical site infection prevention: an updated meta-analysis and trial sequential analysis of randomized controlled trials. Frontiers in Medicine. 2025;12. doi:10.3389/fmed.2025.1641815
BibTeX
@article{Yang2025,
author = {Yang, Shengyi and Li, Zhenwei and Wu, Feiyu and Sun, Liyuan and He, Yulu and Wang, Changxian},
title = {Chlorhexidine versus povidone-iodine for surgical site infection prevention: an updated meta-analysis and trial sequential analysis of randomized controlled trials},
journal = {Frontiers in Medicine},
year = {2025},
volume = {12},
doi = {10.3389/fmed.2025.1641815}
}
EUVIMED